Accessibility Menu
Arrow-Thin-Down
S&P 500
6,800.84
+1.1%
+72.04
Arrow-Thin-Down
DJI
47,139.57
+0.3%
+152.47
Arrow-Thin-Down
NASDAQ
23,413.59
+1.8%
+409.05
Arrow-Thin-Down
Bitcoin
$105,451.00
+1.7%
+$1,729.29
Arrow-Thin-Down
AAPL
$269.17
+0.4%
+$0.96
Arrow-Thin-Down
AMZN
$247.30
+1.2%
+$2.89
Arrow-Thin-Down
GOOG
$287.63
+2.8%
+$7.93
Arrow-Thin-Down
META
$634.64
+2.1%
+$12.93
Arrow-Thin-Down
MSFT
$502.12
+1.1%
+$5.30
Arrow-Thin-Down
NVDA
$196.02
+4.2%
+$7.87
Arrow-Thin-Down
TSLA
$447.18
+4.1%
+$17.66
Daily Stock GainersDaily Stock LosersMost Active Stocks

Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity?

By Parkev Tatevosian, CFA – Aug 2, 2025 at 9:00AM

Competition from all sides is causing Novo Nordisk to revise its expectations for 2025.

Novo Nordisk (NVO +0.49%) is struggling with competition from both compounders and larger rivals.

*Stock prices used were the afternoon prices of July 29, 2025. The video was published on July 31, 2025.

About the Author

Parkev Tatevosian, CFA
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
TMFParkev
X@TMFParkev

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services